Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC744722564;22565;22566 chr2:178722448;178722447;178722446chr2:179587175;179587174;179587173
N2AB713021613;21614;21615 chr2:178722448;178722447;178722446chr2:179587175;179587174;179587173
N2A620318832;18833;18834 chr2:178722448;178722447;178722446chr2:179587175;179587174;179587173
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCC
  • RefSeq wild type template codon: GGG
  • Domain: Ig-59
  • Domain position: 29
  • Structural Position: 43
  • Q(SASA): 0.808
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/S rs749750693 0.027 0.999 N 0.625 0.46 0.493628743246 gnomAD-2.1.1 4.03E-06 None None None None I None 0 0 None 9.96E-05 0 None 0 None 0 0 0
P/S rs749750693 0.027 0.999 N 0.625 0.46 0.493628743246 gnomAD-3.1.2 6.58E-06 None None None None I None 0 0 0 2.88018E-04 0 None 0 0 0 0 0
P/S rs749750693 0.027 0.999 N 0.625 0.46 0.493628743246 gnomAD-4.0.0 2.47938E-06 None None None None I None 0 0 None 1.01392E-04 0 None 0 0 8.47781E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.254 likely_benign 0.201 benign -0.375 Destabilizing 0.987 D 0.645 neutral N 0.482881626 None None I
P/C 0.8981 likely_pathogenic 0.8997 pathogenic -0.621 Destabilizing 1.0 D 0.695 prob.neutral None None None None I
P/D 0.6262 likely_pathogenic 0.6338 pathogenic -0.353 Destabilizing 0.988 D 0.624 neutral None None None None I
P/E 0.5636 ambiguous 0.5308 ambiguous -0.474 Destabilizing 0.95 D 0.632 neutral None None None None I
P/F 0.8709 likely_pathogenic 0.8538 pathogenic -0.685 Destabilizing 1.0 D 0.679 prob.neutral None None None None I
P/G 0.6103 likely_pathogenic 0.633 pathogenic -0.478 Destabilizing 0.999 D 0.623 neutral None None None None I
P/H 0.5468 ambiguous 0.5015 ambiguous -0.091 Destabilizing 1.0 D 0.655 neutral D 0.538475065 None None I
P/I 0.7653 likely_pathogenic 0.7196 pathogenic -0.256 Destabilizing 1.0 D 0.697 prob.neutral None None None None I
P/K 0.7078 likely_pathogenic 0.6526 pathogenic -0.416 Destabilizing 1.0 D 0.619 neutral None None None None I
P/L 0.4569 ambiguous 0.3804 ambiguous -0.256 Destabilizing 1.0 D 0.671 neutral N 0.499037325 None None I
P/M 0.7471 likely_pathogenic 0.6992 pathogenic -0.401 Destabilizing 1.0 D 0.656 neutral None None None None I
P/N 0.5884 likely_pathogenic 0.6005 pathogenic -0.153 Destabilizing 0.999 D 0.662 neutral None None None None I
P/Q 0.4815 ambiguous 0.4207 ambiguous -0.396 Destabilizing 0.989 D 0.527 neutral None None None None I
P/R 0.5136 ambiguous 0.4373 ambiguous 0.084 Stabilizing 1.0 D 0.659 neutral N 0.489326861 None None I
P/S 0.3504 ambiguous 0.3145 benign -0.464 Destabilizing 0.999 D 0.625 neutral N 0.494162253 None None I
P/T 0.3553 ambiguous 0.315 benign -0.488 Destabilizing 0.999 D 0.635 neutral N 0.482121158 None None I
P/V 0.5851 likely_pathogenic 0.5296 ambiguous -0.263 Destabilizing 0.999 D 0.666 neutral None None None None I
P/W 0.9439 likely_pathogenic 0.9415 pathogenic -0.77 Destabilizing 1.0 D 0.708 prob.delet. None None None None I
P/Y 0.8382 likely_pathogenic 0.8271 pathogenic -0.47 Destabilizing 1.0 D 0.681 prob.neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.